Kuidas keskusega ühendust võtta
HCP keskus
AMC / LUMC toimivad ühiskonda mõjutavate rahvatervise valdkonna teemade teadmuskeskustena, omab regioonis suunavat funktsiooni ning tegutseb meditsiinitöötajate täiend- ja täiendõppe keskustena.
AMC / LUMC on haruldaste silmahaiguste eksperdikeskused, kus on sellel teemal aktiivsed kliinilised ja alusuuringud. AMC oftalmogeneetiline andmebaas on üks suurimaid maailmas.
Pilt: Steven Lek
Kontakt
Amsterdam University Medical Center / Leiden University Medical Center
meeskond
Pr Camiel BOON
Holland
Dr Axel PETZOLD
Holland
Kliinilised uuringud
NAC Attack, A Phase III, Multicenter, Randomized, Parallel, Double Masked, Placebo-Controlled Study Evaluating the Efficacy and Safety of Oral N-Acetylcysteine in Patients With Retinitis Pigmentosa
Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Half-dose photodynamic therapy versus eplerenone treatment in chronic centralserous chorioretinopathy.
Natural history of the progression of X-linked retinitis pigmentosa.
Prospective Clinical Trial to Evaluate the Efficacy of Acetazolamide for the Treatment of Cystoid Fluid Collections in Retinoschisis: The AXIS Trial
A multi-national, multi-centre, double-masked, placebo-controlled proof of concept trial to evaluate the safety and efficacy of oral soraprazan in Stargardt disease
Development of Novel Clinical Endpoints for Interventional Clinical Trials With a Regulatory and Patient Access Intention in Patients With Intermediate Age-related Macular Degeneration (AMD)